Ocugen hosted two Pennsylvania state lawmakers at its facility to review its biotech pipeline and discuss HB 2162, a bill with implications for the company and the region’s life-sciences sector. The visit comes as Ocugen expands work in Alzheimer’s and retinal therapies.
published
Ocugen hosted two Pennsylvania state lawmakers at its facility to review its biotech pipeline and discuss HB 2162, a bill with implications for the company and the region’s life-sciences sector. The visit comes as Ocugen expands work in Alzheimer’s and retinal
Latest documented BWB result
$META market result
I sold the $META $655 Puts 9/25 for $7.60
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.